Antiemetics Market is expected to cross USD 6.7 Billion by 2025 at a CAGR of 6.6%. - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Antiemetics Market is expected to cross USD 6.7 Billion by 2025 at a CAGR of 6.6%.

Description:

According to MRFR analysis, Antiemetics Market is expected to register a CAGR of 6.6% during the forecast period of 2019 to 2025 and account for USD 6.7 Billion in 2025. – PowerPoint PPT presentation

Number of Views:0
Date added: 28 January 2020
Slides: 7
Provided by: sagar000777

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Antiemetics Market is expected to cross USD 6.7 Billion by 2025 at a CAGR of 6.6%.


1
Antiemetics Market is expected to cross USD 6.7
Billion by 2025 at a CAGR of 6.6.
SAMPLE
FOR MORE INFO
2
Antiemetics Market
Market Highlights According to MRFR analysis,
Antiemetics Market is expected to register a CAGR
of 6.6 during the forecast period of 2019 to
2025 and account for USD 6.7 Billion in 2025.
The Global Antiemetics Market is expected to
grow at a steady pace. There are numerous
antiemetics agents available for the treatment of
nausea and vomiting, including dopamine
antagonists, anticholinergics, antihistamines,
serotonin antagonists, and others. The key
players manufacturing these products include GSK,
Merck, and Pfizer Inc. As these players generate
their maximum revenue from the Americas for the
market, the region accounted for significant
share across the globe. The market is expected
to grow at a steady growth rate. The significant
factors influencing the growth of the market
include increasing investment in the
pharmaceutical industry, increasing the number of
postoperative procedures, pregnancy-induced
nausea, and acute gastroenteritis, further
influencing the growth of the market. Moreover,
the rising demand for novel therapeutics and the
increasing prevalence of postoperative nausea and
vomiting (PONV) is responsible for positive
market growth. Request For Free Sample Report
https//www.marketresearchfuture.com/sample_reques
t/8454
3
Antiemetics Market
Segmentation The Global Antiemetics Market has
been segmented into agents, drug type,
application, and distribution channel. By agents,
the market has been segmented into dopamine
antagonists, anticholinergics, antihistamines,
serotonin antagonists, cannabinoids, and others.
Furthermore, dopamine antagonists is segmented
into phenothiazines (chlorpromazine,
prochlorperazine), butyrophenones (droperidol,
domperidone ), and benzamides. Moreover,
serotonin antagonists is further divided into
ondansetron, granisetron. The others segment
includes dexamethasone and propofol. Dopamine
accounted for the largest market share majorly
due to FDA approval for the maximum number of
application By drug type, the market is segmented
into prescribed and OTC. Prescribed drugs
accounted for the large share by drugs type due
to the high cost of the drugs when compared to
OTC and also are most prescribed by the
professionals. Browse Full Report Details _at_
https//www.marketresearchfuture.com/reports/antie
metics-market-8454
4
Antiemetics Market
Regional Analysis On a regional basis, the
Americas are anticipated to dominate the global
antiemetics market owing to the growing clinical
research development budgets by both public and
private organizations in the pharmaceutical
industry, increasing demand for novel
therapeutics and the abundant presence of
significant manufacturer in the region.
Additionally, rising postoperative procedures is
expected to influence the growth of the market.
According to a study, it is found that PONV
occurs in nearly 30 of the general surgical
population and up to 70 to 80 of high-risk
surgical patients. Europe is expected to account
for the second-largest market in the global
antiemetics market owing to well-developed
research infrastructure, increasing healthcare
awareness in the region, and high expenditure in
pharmaceutical research. Moreover, rising
healthcare expenditure is boosting the market in
this region. Asia-Pacific is expected to be the
fastest-growing region due to the growing
interest of major key players in entering
emerging markets, increasing development in the
pharmaceutical industry in this region. Moreover,
increasing the adoption of chemotherapy for the
treatment of cancer expected to influence the
growth of the market. The Middle East Africa is
expected to account for the least share of the
global antiemetics market. Moreover, the
significant market share of the region is
expected to be held by the Middle East region
owing to the increasing investment by major
manufacturers and changing healthcare reforms.

5
ABOUT US
MARKET RESEARCH FUTURE At Market Research Future
(MRFR), we enable our customers to unravel the
complexity of various industries through our
Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports
(3R), Continuous-Feed Research (CFR), and Market
Research Consulting Services. MRFR team have
supreme objective to provide the optimum quality
market research and intelligence services to our
clients. Our market research studies by products,
services, technologies, applications, end users,
and market players for global, regional, and
country level market segments, enable our clients
to see more, know more, and do more, which help
to answer all their most important questions. In
order to stay updated with technology and work
process of the industry, MRFR often plans
conducts meet with the industry experts and
industrial visits for its research analyst
members. For more information kindly visit
www.marketresearchfuture.com or contact us at
info_at_marketresearchfuture.com Copyright 2018
Market Research Future All Rights Reserved. This
document contains highly confidential information
and is the sole property of Market Research
Future. No part of it may be circulated, copied,
quoted, or otherwise reproduced without the
written approval of Market Research Future.
6
(No Transcript)
About PowerShow.com